Gapping up
In reaction to strong earnings/guidance:
- MNK +12.7%, PEGA +9.3%, THC +7.5%, PANW +6.3%, DDS +4.9%, VSI +4.7%, TOL +3.7%, DISCA +1.3%, MGLN +1.1%, LL +1.1%, AES +1%, IPI +0.8%.
M&A news:
- MSCC +1.2% (Nearing a deal to be acquired by Microchip (MCHP), according to the WSJ),
- MCHP +0.7% (See Above).
Select cyber security related names showing strength following PANW report:
- CYBR +1.6%, FEYE +0.7%, VMW +0.3%.
Other news:
- DPW +8.9% (announces California finance lending license issued to subsidiary),
- HCA +4.9% (following THC results),
- TTS +4.9% (higher after several Directors disclosed insider purchases),
- SELB +4.4% (initiated with Buy/$30 tgt at Mizuho),
- DBVT +3.8% (light volume after announcing 'positive' prelim results from Phase II study of Viaskin Milk in milk-allergic patients; Company will assess next steps on any potential protocol changes with regulatory authorities),
- UVXY +3.3% (ProShare Capital Management announces that the investment objective of UVXY & SVXY will change effective as of close of business on February 27),
- NXTD +2.2% (after closing up ~25% on the day),
- QCOM +1.4% (Qualcomm calls Broadcom comments 'misleading'; Qualcomm has no intention of delaying the annual meeting),
- DISCA +1.3% (following SNI earnings and ahead of its own earnings release tomorrow before the open; receives U.S. Department of Justice clearance to acquire Scripps Networks Interactive).
Analyst comments:
- ABIO +20.1% (Initiated with a Buy at Ascendiant Capital Mkts),
- ECYT +5.9% (Upgraded to Outperform from Market Perform at Cowen),
- SELB +4.4% (Initiated with a Buy at Mizuho),
- EXAS +2.9% (Upgraded to Outperform from Neutral at Robert W. Baird),
- CMG +2.1% (Upgraded to Outperform from Neutral at Robert W. Baird),
- WGO +1.8% (Upgraded to Outperform from Market Perform at BMO Capital Markets),
- MMYT +1.8% (upgraded to Overweight at J.P. Morgan),
- RUSHA +1.2% (upgraded to Buy at Buckingham),
- QRVO +0.9% (Initiated with a Overweight at Piper Jaffray).
![]()